SynthesisMedicine2020

Treatment of chronic hepatitis C regiments containing with recombinant interferon in patients with sustained virological response predicts risk of hepatocellular carcinoma: A meta-analysis.

Chien-Feng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.